1. Home
  2. PSIX vs JANX Comparison

PSIX vs JANX Comparison

Compare PSIX & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PSIX

Power Solutions International Inc.

HOLD

Current Price

$66.07

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$15.00

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSIX
JANX
Founded
1985
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PSIX
JANX
Price
$66.07
$15.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
12
Target Price
$98.76
$62.00
AVG Volume (30 Days)
506.2K
2.5M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
122.27
N/A
EPS
5.26
N/A
Revenue
$675,481,000.00
$10,000,000.00
Revenue This Year
$48.27
N/A
Revenue Next Year
$14.25
N/A
P/E Ratio
$11.97
N/A
Revenue Growth
54.78
N/A
52 Week Low
$15.30
$15.16
52 Week High
$121.78
$64.90

Technical Indicators

Market Signals
Indicator
PSIX
JANX
Relative Strength Index (RSI) 53.89 28.15
Support Level $60.49 $16.00
Resistance Level $62.26 $17.13
Average True Range (ATR) 3.76 1.42
MACD 2.25 -1.12
Stochastic Oscillator 94.88 0.73

Price Performance

Historical Comparison
PSIX
JANX

About PSIX Power Solutions International Inc.

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: